These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 395955)

  • 1. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E; Recalcati P; Tantalo V; Bregnani P
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A; Liverta C; Pollini C
    Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
    Forette F; Varin D; Henry JF; Hervy MP
    Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of nicergoline on cerebral blood flow (author's transl)].
    Iliff LD; Du Boulay GH; Marshall J; Ross Russell RW; Symon L
    Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathology of the inner ear and therapy of presbyacusis (author's transl)].
    Aliprandi G; Tantalo V
    Arzneimittelforschung; 1979; 29(8a):1287-95. PubMed ID: 540074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicergoline and platelet aggregation. A review of experimental and clinical studies (author's transl)].
    Praga C; Tantalo V; Marangoni R
    Arzneimittelforschung; 1979; 29(8a):1270-6. PubMed ID: 540070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
    Kugler J; Heidrich H
    Fortschr Med; 1984 Nov; 102(42):1091-6. PubMed ID: 6392047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
    Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
    Michelangeli J; Sevilla M; Lavagna J; Darcourt G
    Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
    Marolda M; Fragassi N; Buscaino GA
    Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
    Bossi L
    Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nicergoline on the intellectual performance (author's transl)].
    Donoso A; Santander M; Sarce H
    Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.